Kymera Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
PRICE T ROWE ASSOCIATES INC /MD/ | 05/14/2025 | 6.70 M | $183.45 M | -2.44% | 8.36% |
AVORO CAPITAL ADVISORS LLC | 05/15/2025 | 6.46 M | $176.81 M | 25.44% | 8.06% |
WELLINGTON MANAGEMENT GROUP LLP | 05/13/2025 | 6.00 M | $164.13 M | 12.99% | 7.48% |
BAKER BROS. ADVISORS LP | 05/15/2025 | 6.00 M | $164.11 M | 0.00% | 7.48% |
VANGUARD GROUP INC | 05/09/2025 | 5.23 M | $143.18 M | 7.04% | 6.53% |
BVF INC/IL | 05/15/2025 | 5.16 M | $141.28 M | 0.00% | 6.44% |
ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC | 05/14/2025 | 4.90 M | $134.02 M | 0.00% | 6.11% |
FMR LLC | 05/12/2025 | 4.41 M | $120.68 M | -8.72% | 5.50% |
BLACKROCK, INC. | 05/02/2025 | 4.28 M | $117.22 M | -1.68% | 5.34% |
SIREN, L.L.C. | 05/23/2025 | 3.24 M | $88.69 M | 9.11% | 4.04% |
STATE STREET CORP | 05/15/2025 | 1.76 M | $48.19 M | 4.26% | 2.20% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 05/15/2025 | 1.17 M | $31.99 M | -15.94% | 1.46% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 1.13 M | $31.04 M | 2.56% | 1.41% |
REDMILE GROUP, LLC | 05/15/2025 | 983.41 K | $26.92 M | -10.63% | 1.23% |
UBS ASSET MANAGEMENT AMERICAS INC | 05/19/2025 | 896.40 K | $24.53 M | 121.52% | 1.12% |
ROCK SPRINGS CAPITAL MANAGEMENT LP | 05/15/2025 | 794.44 K | $21.74 M | -23.18% | 0.99% |
MERCK & CO., INC. | 05/14/2025 | 772.17 K | $21.13 M | 0.00% | 0.96% |
JANUS HENDERSON GROUP PLC | 05/15/2025 | 770.58 K | $22.81 M | 104.19% | 0.96% |
UBS GROUP AG | 05/13/2025 | 593.61 K | $16.25 M | 26.34% | 0.74% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 05/15/2025 | 593.00 K | $16.23 M | 0.00% | 0.74% |
JENNISON ASSOCIATES LLC | 05/05/2025 | 552.29 K | $15.12 M | -22.97% | 0.69% |
WOODLINE PARTNERS LP | 05/15/2025 | 525.25 K | $14.38 M | -2.27% | 0.66% |
EVENTIDE ASSET MANAGEMENT, LLC | 05/15/2025 | 525.14 K | $14.37 M | 15.23% | 0.66% |
MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 510.48 K | $13.97 M | 340.38% | 0.64% |
AJU IB INVESTMENT CO., LTD. | 04/08/2025 | 457.06 K | $12.51 M | 0.00% | 0.57% |
NORTHERN TRUST CORP | 05/13/2025 | 421.66 K | $11.54 M | -3.69% | 0.53% |
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 05/02/2025 | 420.05 K | $11.50 M | 0.13% | 0.52% |
DEER MANAGEMENT CO. LLC | 05/15/2025 | 415.90 K | $11.38 M | 0.00% | 0.52% |
DIMENSIONAL FUND ADVISORS LP | 05/13/2025 | 395.47 K | $10.83 M | -8.83% | 0.49% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 381.71 K | $10.45 M | -1.42% | 0.48% |
CAPITAL RESEARCH GLOBAL INVESTORS | 05/12/2025 | 365.19 K | $10.00 M | 100.00% | 0.46% |
GOLDMAN SACHS GROUP INC | 06/27/2025 | 344.24 K | $9.42 M | -20.67% | 0.43% |
05/15/2025 | 325.00 K | $8.90 M | -23.53% | 0.41% | |
GILDER GAGNON HOWE & CO LLC | 05/15/2025 | 318.38 K | $8.71 M | -2.44% | 0.40% |
TD ASSET MANAGEMENT INC | 05/07/2025 | 202.09 K | $5.53 M | -11.58% | 0.25% |
MARSHALL WACE, LLP | 05/15/2025 | 201.90 K | $5.53 M | 2,853.91% | 0.25% |
TWO SIGMA ADVISERS, LP | 05/15/2025 | 183.30 K | $5.02 M | -29.58% | 0.23% |
IKARIAN CAPITAL, LLC | 05/15/2025 | 176.80 K | $4.84 M | 100.00% | 0.22% |
MORGAN STANLEY | 05/15/2025 | 172.08 K | $4.71 M | -28.23% | 0.21% |
SCHRODER INVESTMENT MANAGEMENT GROUP | 05/13/2025 | 158.34 K | $4.69 M | -3.39% | 0.20% |
TWO SIGMA INVESTMENTS, LP | 05/15/2025 | 147.62 K | $4.04 M | -15.04% | 0.18% |
FORESITE CAPITAL MANAGEMENT VI LLC | 05/15/2025 | 146.33 K | $4.01 M | 0.00% | 0.18% |
VOLORIDGE INVESTMENT MANAGEMENT, LLC | 05/15/2025 | 144.22 K | $3.95 M | -2.05% | 0.18% |
05/12/2025 | 143.24 K | $3.92 M | 100.00% | 0.18% | |
MANUFACTURERS LIFE INSURANCE COMPANY, THE | 05/15/2025 | 142.59 K | $3.90 M | -3.20% | 0.18% |
PATIENT SQUARE CAPITAL LP | 05/14/2025 | 142.20 K | $3.89 M | 100.00% | 0.18% |
AQUILO CAPITAL MANAGEMENT, LLC | 05/15/2025 | 138.52 K | $3.79 M | -24.52% | 0.17% |
CHECKPOINT CAPITAL L.P. | 05/15/2025 | 136.61 K | $3.74 M | 76.18% | 0.17% |
FRONTIER CAPITAL MANAGEMENT CO LLC | 05/15/2025 | 131.96 K | $3.61 M | -12.13% | 0.16% |
BANK OF NEW YORK MELLON CORP | 04/29/2025 | 126.88 K | $3.47 M | -0.17% | 0.16% |
Kymera Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 203 institutional investors and hedge funds held shares of Kymera Therapeutics, Inc.. The most heavily invested institutionals were:
PRICE T ROWE ASSOCIATES INC /MD/: 6.7 M
Avoro Capital Advisors LLC: 6.46 M
WELLINGTON MANAGEMENT GROUP LLP: 6 M
BAKER BROS. ADVISORS LP: 6 M
VANGUARD GROUP INC: 5.23 M
BVF INC/IL: 5.16 M
90.84% of Kymera Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 77.99 M shares in the last 24 months. This purchase volume represents approximately $3.49 B in transactions.